Literature DB >> 18351367

Detection of human cytomegalovirus in different histological types of gliomas.

Michael E Scheurer1, Melissa L Bondy, Kenneth D Aldape, Thomas Albrecht, Randa El-Zein.   

Abstract

The association between human cytomegalovirus (HCMV) infection and glioblastoma has been a source of debate in recent years because of conflicting laboratory reports concerning the presence of the virus in glioma tissue. HCMV is a ubiquitous herpesvirus that exhibits tropism for glial cells and has been shown to transform cells in vitro. Using sensitive immunohistochemical and in situ hybridization methods in 50 glioma samples, we detected HCMV antigen and DNA in 21/21 cases of glioblastoma, 9/12 cases of anaplastic gliomas and 14/17 cases of low-grade gliomas. Reactivity against the HCMV IE1 antigen (72 kDa) exhibited histology-specific patterns with more nuclear staining for anaplastic and low-grade gliomas, while GBMs showed nuclear and cytoplasmic staining that likely occurs with latent infection. Using IHC, the number of HCMV-positive cells in GBMs was 79% compared to 48% in lower grade tumors. Non-tumor areas of the tissue contained only four and 1% of HCMV-positive cells for GBMs and lower grade tumors, respectively. Hybridization to HCMV DNA in infected cells corresponded to patterns of immunoreactivity. Our findings support previous reports of the presence of HCMV infection in glioma tissues and advocate optimization of laboratory methods for the detection of active HCMV infections. This will allow for detection of low-level latent infections that may play an important role in the initiation and/or promotion of malignant gliomas.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18351367      PMCID: PMC3001277          DOI: 10.1007/s00401-008-0359-1

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  35 in total

1.  Polio vaccination and risk of brain tumors in adults: no apparent association.

Authors:  Alina V Brenner; Martha S Linet; Robert G Selker; William R Shapiro; Peter M Black; Howard A Fine; Peter D Inskip
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-02       Impact factor: 4.254

2.  Induction of latent human cytomegalovirus by conventional gamma irradiation and prevention by treatment with INACTINE PEN110.

Authors:  A Ohagen; V Gibaja; J Horrigan; D Lunderville; V Jayarama; J Marcello; J Chapman; A Lazo
Journal:  Vox Sang       Date:  2004-07       Impact factor: 2.144

3.  Prevalence of antibodies to four herpesviruses among adults with glioma and controls.

Authors:  M Wrensch; A Weinberg; J Wiencke; R Miike; G Barger; K Kelsey
Journal:  Am J Epidemiol       Date:  2001-07-15       Impact factor: 4.897

4.  Human cytomagalovirus IE1 and IE2 proteins are mutagenic and mediate "hit-and-run" oncogenic transformation in cooperation with the adenovirus E1A proteins.

Authors:  Y Shen; H Zhu; T Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

5.  High prevalence of human cytomegalovirus in prostatic intraepithelial neoplasia and prostatic carcinoma.

Authors:  Minu Samanta; Lualhati Harkins; Katrin Klemm; William J Britt; Charles S Cobbs
Journal:  J Urol       Date:  2003-09       Impact factor: 7.450

6.  Subclinical activation of latent cytomegalovirus (CMV) infection and anti-CMV immune response in patients with atopic dermatitis.

Authors:  W-D Döcke; C Kiessling; M Worm; M Friedrich; A Pruss; M Weitz; S Prösch; F Kern; H-D Volk; W Sterry; K Asadullah
Journal:  Br J Dermatol       Date:  2003-05       Impact factor: 9.302

7.  Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer.

Authors:  Lualhati Harkins; Andrea L Volk; Minu Samanta; Ivan Mikolaenko; William J Britt; Kirby I Bland; Charles S Cobbs
Journal:  Lancet       Date:  2002-11-16       Impact factor: 79.321

8.  Differential mutagen sensitivity of peripheral blood lymphocytes from smokers and nonsmokers: effect of human cytomegalovirus infection.

Authors:  Thomas Albrecht; Cheng Zong Deng; Sherif Z Abdel-Rahman; Michael Fons; Paul Cinciripini; Randa A El-Zein
Journal:  Environ Mol Mutagen       Date:  2004       Impact factor: 3.216

9.  Human cytomegalovirus infection and expression in human malignant glioma.

Authors:  Charles S Cobbs; Lualhati Harkins; Minu Samanta; G Yancey Gillespie; Suman Bharara; Peter H King; L Burt Nabors; C Glenn Cobbs; William J Britt
Journal:  Cancer Res       Date:  2002-06-15       Impact factor: 12.701

10.  Human cytomegalovirus in neoplastic cells of Epstein-Barr virus negative Hodgkin's disease.

Authors:  Gaosheng Huang; Qingguo Yan; Zhe Wang; Xiequn Chen; Xiaohui Zhang; Ying Guo; Jian Jian Li
Journal:  Int J Oncol       Date:  2002-07       Impact factor: 5.650

View more
  114 in total

Review 1.  The role of cytomegalovirus in angiogenesis.

Authors:  Patrizia Caposio; Susan L Orloff; Daniel N Streblow
Journal:  Virus Res       Date:  2010-10-01       Impact factor: 3.303

2.  Generation of polyclonal CMV-specific T cells for the adoptive immunotherapy of glioblastoma.

Authors:  Alexia Ghazi; Aidin Ashoori; Patrick J Hanley; Vita S Brawley; Donald R Shaffer; Yvonne Kew; Suzanne Z Powell; Robert Grossman; Zakaria Grada; Michael E Scheurer; Meenakshi Hegde; Ann M Leen; Catherine M Bollard; Cliona M Rooney; Helen E Heslop; Stephen Gottschalk; Nabil Ahmed
Journal:  J Immunother       Date:  2012 Feb-Mar       Impact factor: 4.456

3.  Human cytomegalovirus infection in tumor cells of the nervous system is not detectable with standardized pathologico-virological diagnostics.

Authors:  Peter Baumgarten; Martin Michaelis; Florian Rothweiler; Tatjana Starzetz; Holger F Rabenau; Annemarie Berger; Lukas Jennewein; Anne K Braczynski; Kea Franz; Volker Seifert; Joachim P Steinbach; Regina Allwinn; Michel Mittelbronn; Jindrich Cinatl
Journal:  Neuro Oncol       Date:  2014-08-25       Impact factor: 12.300

Review 4.  Is HCMV a tumor promoter?

Authors:  Liliana Soroceanu; Charles S Cobbs
Journal:  Virus Res       Date:  2010-10-29       Impact factor: 3.303

5.  Consensus on the role of human cytomegalovirus in glioblastoma.

Authors:  Kristine Dziurzynski; Susan M Chang; Amy B Heimberger; Robert F Kalejta; Stuart R McGregor Dallas; Martine Smit; Liliana Soroceanu; Charles S Cobbs
Journal:  Neuro Oncol       Date:  2012-02-08       Impact factor: 12.300

6.  Glioma-associated cytomegalovirus mediates subversion of the monocyte lineage to a tumor propagating phenotype.

Authors:  Kristine Dziurzynski; Jun Wei; Wei Qiao; Mustafa Aziz Hatiboglu; Ling-Yuan Kong; Adam Wu; Yongtao Wang; Daniel Cahill; Nicholas Levine; Sujit Prabhu; Ganesh Rao; Raymond Sawaya; Amy B Heimberger
Journal:  Clin Cancer Res       Date:  2011-04-13       Impact factor: 12.531

Review 7.  Immunotherapy of malignant gliomas using autologous and allogeneic tissue cells.

Authors:  F M Hofman; A Stathopoulos; C A Kruse; T C Chen; V E J C Schijns
Journal:  Anticancer Agents Med Chem       Date:  2010-07       Impact factor: 2.505

Review 8.  Oncomodulation by human cytomegalovirus: evidence becomes stronger.

Authors:  Martin Michaelis; Hans Wilhelm Doerr; Jindrich Cinatl
Journal:  Med Microbiol Immunol       Date:  2009-02-07       Impact factor: 3.402

Review 9.  Design and development of therapies using chimeric antigen receptor-expressing T cells.

Authors:  Gianpietro Dotti; Stephen Gottschalk; Barbara Savoldo; Malcolm K Brenner
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

10.  The association between birth order, sibship size and glioma development in adulthood.

Authors:  E Amirian; Michael E Scheurer; Melissa L Bondy
Journal:  Int J Cancer       Date:  2010-06-01       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.